US Stock MarketDetailed Quotes

CNS Pharmaceuticals (CNSP)

Watchlist
  • 2.311
  • +0.041+1.81%
Close May 1 16:00 ET
  • 2.311
  • 0.0000.00%
Post 20:01 ET
1.88MMarket Cap-0.06P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CNS Pharmaceuticals (CNSP) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
11.45%7.2M
11.45%7.2M
41.46%9.86M
713.23%12.13M
1,500.49%13.05M
1,077.53%6.46M
1,077.53%6.46M
666.66%6.97M
-65.14%1.49M
-84.05%815.23K
-Cash and cash equivalents
11.45%7.2M
11.45%7.2M
41.46%9.86M
713.23%12.13M
1,500.49%13.05M
1,077.53%6.46M
1,077.53%6.46M
666.66%6.97M
-65.14%1.49M
-84.05%815.23K
Receivables
--0
--0
--0
--0
--0
--882.54K
--882.54K
----
----
----
-Accounts receivable
--0
--0
--0
--0
--0
--882.54K
--882.54K
----
----
----
Current deferred assets
120.41%45.49K
120.41%45.49K
62.26%43.7K
-15.39%14.17K
--20.64K
-89.83%20.64K
-89.83%20.64K
--26.93K
--16.75K
--0
Other current assets
-33.82%856.3K
-33.82%856.3K
282.42%1.48M
212.95%1.99M
-16.83%653.8K
54.12%1.29M
54.12%1.29M
-66.32%388.04K
-64.44%637.09K
-57.78%786.05K
Total current assets
-6.42%8.1M
-6.42%8.1M
54.19%11.39M
558.98%14.14M
756.94%13.72M
444.16%8.66M
444.16%8.66M
258.32%7.39M
-64.66%2.15M
-77.03%1.6M
Non current assets
Net PPE
194.80%17.7K
194.80%17.7K
10.89%3.11K
7.06%3.8K
13.94%4.91K
21.73%6.01K
21.73%6.01K
-19.25%2.8K
5.06%3.55K
-1.82%4.31K
Non current prepaid assets
1,280.63%502.96K
1,280.63%502.96K
2,482.14%474.42K
14.34%366.25K
-59.52%22.38K
-65.22%36.43K
-65.22%36.43K
-93.01%18.37K
-15.08%320.32K
-87.38%55.3K
Total non current assets
1,126.97%520.67K
1,126.97%520.67K
2,155.13%477.52K
14.26%370.06K
-54.21%27.29K
-61.31%42.44K
-61.31%42.44K
-92.05%21.18K
-14.90%323.87K
-86.53%59.6K
Total assets
-0.89%8.62M
-0.89%8.62M
60.19%11.87M
487.54%14.51M
727.83%13.75M
411.56%8.7M
411.56%8.7M
218.26%7.41M
-61.73%2.47M
-77.60%1.66M
Liabilities
Current liabilities
Current debt and capital lease obligation
0.77%328.57K
0.77%328.57K
-1.26%30.79K
-1.20%121.77K
-1.14%210.67K
8.40%326.07K
8.40%326.07K
-25.58%31.19K
-25.93%123.25K
-26.28%213.1K
-Current debt
0.77%328.57K
0.77%328.57K
-1.26%30.79K
-1.20%121.77K
-1.14%210.67K
8.40%326.07K
8.40%326.07K
-25.58%31.19K
-25.93%123.25K
-26.28%213.1K
Current liabilities
62.46%4.1M
62.46%4.1M
-51.71%1.96M
-79.55%1.38M
-54.38%2.78M
-58.84%2.52M
-58.84%2.52M
-0.29%4.06M
69.19%6.76M
55.28%6.09M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
62.46%4.1M
62.46%4.1M
-51.71%1.96M
-79.55%1.38M
-54.38%2.78M
-58.84%2.52M
-58.84%2.52M
-0.29%4.06M
69.19%6.76M
55.28%6.09M
Shareholders'equity
Share capital
436.44%633
436.44%633
-98.28%574
-65.07%504
-72.40%2.95K
5,800.00%118
5,800.00%118
695.01%33.45K
-65.15%1.44K
379.29%10.67K
-common stock
436.44%633
436.44%633
-98.28%574
-65.07%504
-72.40%2.95K
5,800.00%118
5,800.00%118
695.01%33.45K
-65.15%1.44K
379.29%10.67K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-18.77%-100.28M
-18.77%-100.28M
-16.09%-94.32M
-20.44%-91.1M
-21.36%-88.73M
-21.36%-84.42M
-21.36%-84.42M
-26.57%-81.25M
-26.77%-75.64M
-31.38%-73.11M
Paid-in capital
15.67%104.8M
15.67%104.8M
23.25%104.23M
46.08%104.23M
45.18%99.69M
39.10%90.6M
39.10%90.6M
35.42%84.57M
14.86%71.35M
16.12%68.67M
Total stockholders'equity
-26.78%4.52M
-26.78%4.52M
195.62%9.91M
405.69%13.12M
347.60%10.97M
239.36%6.18M
239.36%6.18M
292.58%3.35M
-274.93%-4.29M
-226.88%-4.43M
Total equity
-26.78%4.52M
-26.78%4.52M
195.62%9.91M
405.69%13.12M
347.60%10.97M
239.36%6.18M
239.36%6.18M
292.58%3.35M
-274.93%-4.29M
-226.88%-4.43M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 11.45%7.2M11.45%7.2M41.46%9.86M713.23%12.13M1,500.49%13.05M1,077.53%6.46M1,077.53%6.46M666.66%6.97M-65.14%1.49M-84.05%815.23K
-Cash and cash equivalents 11.45%7.2M11.45%7.2M41.46%9.86M713.23%12.13M1,500.49%13.05M1,077.53%6.46M1,077.53%6.46M666.66%6.97M-65.14%1.49M-84.05%815.23K
Receivables --0--0--0--0--0--882.54K--882.54K------------
-Accounts receivable --0--0--0--0--0--882.54K--882.54K------------
Current deferred assets 120.41%45.49K120.41%45.49K62.26%43.7K-15.39%14.17K--20.64K-89.83%20.64K-89.83%20.64K--26.93K--16.75K--0
Other current assets -33.82%856.3K-33.82%856.3K282.42%1.48M212.95%1.99M-16.83%653.8K54.12%1.29M54.12%1.29M-66.32%388.04K-64.44%637.09K-57.78%786.05K
Total current assets -6.42%8.1M-6.42%8.1M54.19%11.39M558.98%14.14M756.94%13.72M444.16%8.66M444.16%8.66M258.32%7.39M-64.66%2.15M-77.03%1.6M
Non current assets
Net PPE 194.80%17.7K194.80%17.7K10.89%3.11K7.06%3.8K13.94%4.91K21.73%6.01K21.73%6.01K-19.25%2.8K5.06%3.55K-1.82%4.31K
Non current prepaid assets 1,280.63%502.96K1,280.63%502.96K2,482.14%474.42K14.34%366.25K-59.52%22.38K-65.22%36.43K-65.22%36.43K-93.01%18.37K-15.08%320.32K-87.38%55.3K
Total non current assets 1,126.97%520.67K1,126.97%520.67K2,155.13%477.52K14.26%370.06K-54.21%27.29K-61.31%42.44K-61.31%42.44K-92.05%21.18K-14.90%323.87K-86.53%59.6K
Total assets -0.89%8.62M-0.89%8.62M60.19%11.87M487.54%14.51M727.83%13.75M411.56%8.7M411.56%8.7M218.26%7.41M-61.73%2.47M-77.60%1.66M
Liabilities
Current liabilities
Current debt and capital lease obligation 0.77%328.57K0.77%328.57K-1.26%30.79K-1.20%121.77K-1.14%210.67K8.40%326.07K8.40%326.07K-25.58%31.19K-25.93%123.25K-26.28%213.1K
-Current debt 0.77%328.57K0.77%328.57K-1.26%30.79K-1.20%121.77K-1.14%210.67K8.40%326.07K8.40%326.07K-25.58%31.19K-25.93%123.25K-26.28%213.1K
Current liabilities 62.46%4.1M62.46%4.1M-51.71%1.96M-79.55%1.38M-54.38%2.78M-58.84%2.52M-58.84%2.52M-0.29%4.06M69.19%6.76M55.28%6.09M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 62.46%4.1M62.46%4.1M-51.71%1.96M-79.55%1.38M-54.38%2.78M-58.84%2.52M-58.84%2.52M-0.29%4.06M69.19%6.76M55.28%6.09M
Shareholders'equity
Share capital 436.44%633436.44%633-98.28%574-65.07%504-72.40%2.95K5,800.00%1185,800.00%118695.01%33.45K-65.15%1.44K379.29%10.67K
-common stock 436.44%633436.44%633-98.28%574-65.07%504-72.40%2.95K5,800.00%1185,800.00%118695.01%33.45K-65.15%1.44K379.29%10.67K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -18.77%-100.28M-18.77%-100.28M-16.09%-94.32M-20.44%-91.1M-21.36%-88.73M-21.36%-84.42M-21.36%-84.42M-26.57%-81.25M-26.77%-75.64M-31.38%-73.11M
Paid-in capital 15.67%104.8M15.67%104.8M23.25%104.23M46.08%104.23M45.18%99.69M39.10%90.6M39.10%90.6M35.42%84.57M14.86%71.35M16.12%68.67M
Total stockholders'equity -26.78%4.52M-26.78%4.52M195.62%9.91M405.69%13.12M347.60%10.97M239.36%6.18M239.36%6.18M292.58%3.35M-274.93%-4.29M-226.88%-4.43M
Total equity -26.78%4.52M-26.78%4.52M195.62%9.91M405.69%13.12M347.60%10.97M239.36%6.18M239.36%6.18M292.58%3.35M-274.93%-4.29M-226.88%-4.43M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -